Niagen IV vs NAD+ IV: Time, Tolerability and Evidence

Niagen IV delivers nicotinamide riboside (NR), a precursor, rather than NAD+ itself. A small 2026 retrospective clinic study found shorter infusions and fewer intense symptoms with NR. It did not show that either infusion improves long-term health ¹.

That distinction is useful when comparing appointment options. A more comfortable visit is a meaningful difference, but it is not the same claim as better energy, healthier aging or longer-lasting benefit.

Featured partner

CoreAge Rx

From $93/mo

Check availabilityRead our review

Affiliate link. We may earn a commission at no extra cost to you.

Affiliate partner

Willow

NAD+ injection alongside a compounded GLP-1 line

See Willow↗

What did the 2026 comparison actually find?

The study reviewed 14 clients: 6 receiving NAD+ and 8 receiving NR. Mean infusion times were about 97 and 37 minutes respectively. Symptoms were more intense in the NAD+ group ¹.

The limitations belong beside those numbers: this was retrospective, small and nonrandomized, with short follow-up. Restore Hyper Wellness funded it; Niagen Biosciences donated NR; all authors were Restore employees. Those features limit confidence and generalizability ¹.

Why faster does not mean better for your goal

Infusion duration depends on the protocol, amount, tolerance and clinic practice. These averages are not a promise for your appointment, and they should never become a target for increasing a drip's rate. The clinician should manage treatment and assess symptoms.

If a clinic quotes the study as proof of rejuvenation, ask which patient-centered outcome supports that statement. A tolerability comparison cannot establish improved concentration, exercise capacity or disease prevention. Our IV evidence review addresses the larger evidence gap.

Does oral NR evidence establish an IV benefit?

No. In an oral NR trial in 12 older men, NAD-related muscle metabolites changed without improved mitochondrial bioenergetics ². Even evidence from the same ingredient requires attention to route, dose, population and outcome.

The NAD+ basics guide explains why “raises NAD+” is a narrower claim than “makes you feel better.” The NR benefits review is relevant if you are also considering a capsule.

What about price?

Compare an itemized quote for the actual visit rather than assuming the shorter option costs less. Ask about the substance and amount, prescriber evaluation, administration, extra ingredients, follow-up and cancellation terms. This article does not provide an unverified national Niagen IV price range.

The NAD+ IV cost guide explains the components of an infusion bill. A prepaid series lowers flexibility as well as the advertised per-session price, especially when benefit is uncertain.

What should you ask before booking?

Confirm who prescribes and administers the infusion, where the preparation comes from and how the clinic monitors symptoms. Ask what happens if you need to stop early. The IV safety checklist covers these questions in detail.

If time at a clinic is the reason you are considering shots instead, compare the evidence and practical tradeoffs in IV versus injection versus oral NAD+. A different route changes the decision; it does not automatically preserve the same effects.

The protocol matters as much as the headline

Clients in the retrospective study received four consecutive days of 500 mg infusions, with follow-up at 30 days ¹. Those details help identify what was studied. They do not establish an appropriate schedule for someone booking a single visit, and they are not instructions for self-administration.

The study did not randomly assign a large, blinded sample to matching treatment groups. That leaves uncertainty about how participant differences, treatment choices and symptom reporting affected the comparison. The short follow-up also cannot settle long-term benefit or uncommon risks.

A further issue is what the word “safety” means in the summary. The paper assessed selected laboratory measures and recorded clinical experiences. A lack of a significant change in a lab test is one specific observation, not a demonstration that repeated treatment is harmless. Different symptoms, rare events or outcomes outside those tests may require a different design and a much larger sample.

What outcome would make a different choice reasonable?

If your main concern is how long an appointment takes, preliminary tolerability information may be relevant. Ask the clinic how its own protocol differs from the study and what happens if you need a slower or interrupted session. Do not book a tight onward schedule around a research average.

If your goal is less fatigue or improved exercise, ask for evidence measuring that outcome. A faster infusion does not tell you whether it happens. The same distinction applies to a claim that NR is “more efficient”: clarify whether that means shorter chair time, a biomarker response or a clinically meaningful improvement.

Compare the full visit, not just the drip

An appointment can include a consultation, screening, preparation, observation and aftercare beyond the infusion itself. Ask whether those services are included in the quoted price and who provides them. A lower headline price can become a different comparison if mandatory evaluation or add-ons are separate.

If a clinic recommends a series, ask what would justify stopping early for lack of benefit and whether unused sessions are refundable. A study using repeated sessions does not validate an automatically renewing package. The useful decision is the one where the intended benefit, remaining uncertainty, time and complete cost are all clear.